RICHARD H MATTHEWS
Medical Practice at Winding Rdg Dr, Jackson, MO
License number
Florida 121602
Issued Date
Sep 15, 2014
Effective Date
Sep 15, 2014
Expiration Date
Jan 31, 2019
Category
Health Care
Type
Medical Doctor
Address
Address
700 Winding Ridge Dr, Jackson, MO 63755
Phone
(573) 335-9983
Professional information
Dr. Richard H Matthews, Jackson MO - MD (Doctor of Medicine)
Specialties:
Radiation Oncology
Address:
700 Winding Ridge Dr, Jackson 63755
(573) 335-9983 (Phone), (573) 335-9984 (Fax)
FARMINGTON REGIONAL RADIATION THERAPY
1175 E Karsch Blvd, Farmington 63640
(573) 756-6797 (Phone), (573) 756-6147 (Fax)
SUMMA BARBERTON HOSPITAL
155 5Th St NE, Barberton 44203
(330) 615-3000 (Phone)
UNIVERSITY HOSPITALS OF CLEVELAND
11100 Euclid Ave, Cleveland 44106
(216) 844-8447 (Phone), (216) 844-1632 (Fax)
RADIATION ONCOLOGY PHYSICIANS
885 S Sawburg Ave STE 108, Alliance 44601
(330) 823-1000 (Phone), (330) 823-3084 (Fax)
(573) 335-9983 (Phone), (573) 335-9984 (Fax)
FARMINGTON REGIONAL RADIATION THERAPY
1175 E Karsch Blvd, Farmington 63640
(573) 756-6797 (Phone), (573) 756-6147 (Fax)
SUMMA BARBERTON HOSPITAL
155 5Th St NE, Barberton 44203
(330) 615-3000 (Phone)
UNIVERSITY HOSPITALS OF CLEVELAND
11100 Euclid Ave, Cleveland 44106
(216) 844-8447 (Phone), (216) 844-1632 (Fax)
RADIATION ONCOLOGY PHYSICIANS
885 S Sawburg Ave STE 108, Alliance 44601
(330) 823-1000 (Phone), (330) 823-3084 (Fax)
Certifications:
Radiation Oncology
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
700 Winding Ridge Dr, Jackson 63755
RADIATION ONCOLOGY PHYSICIANS
885 S Sawburg Ave STE 108, Alliance 44601
SUMMA BARBERTON HOSPITAL
155 5Th St NE, Barberton 44203
UNIVERSITY HOSPITALS OF CLEVELAND
11100 Euclid Ave, Cleveland 44106
FARMINGTON REGIONAL RADIATION THERAPY
1175 E Karsch Blvd, Farmington 63640
Mineral Area Regional Medical Center
1212 Weber Rd, Farmington 63640
Missouri Delta Medical Center
1008 North Main St, Sikeston 63801
RADIATION ONCOLOGY PHYSICIANS
885 S Sawburg Ave STE 108, Alliance 44601
SUMMA BARBERTON HOSPITAL
155 5Th St NE, Barberton 44203
UNIVERSITY HOSPITALS OF CLEVELAND
11100 Euclid Ave, Cleveland 44106
FARMINGTON REGIONAL RADIATION THERAPY
1175 E Karsch Blvd, Farmington 63640
Mineral Area Regional Medical Center
1212 Weber Rd, Farmington 63640
Missouri Delta Medical Center
1008 North Main St, Sikeston 63801
Education:
Medical School
Ohio State University / College of Medicine
Graduated: 1983
Riverside Methodist Hospital
MD Anderson
Ohio State University / College of Medicine
Graduated: 1983
Riverside Methodist Hospital
MD Anderson
Radiosensitizer Formulations And Methods For Use
US Patent:
7608612, Oct 27, 2009
Filed:
Jan 20, 2006
Appl. No.:
11/336419
Inventors:
Richard H. Matthews - Jackson MO, US
Nuran Ercal - Rolla MO, US
Robert Zand - Ann Arbor MI, US
Nuran Ercal - Rolla MO, US
Robert Zand - Ann Arbor MI, US
International Classification:
A61K 31/33, A01N 43/00
US Classification:
514183, 514 94, 5483351
Abstract:
The present invention provides radiosensitizer compositions, in controlled-release formulations or other acceptable formulations, particularly nitrohistidine radiosensitizer compositions, which may be administered by any suitable means including oral, intravenous, arterial infusion, intraperitoneal, intramuscular, subcutaneous, surgical, and topical. Optionally, radiosensitizer compositions may be formulated with other agents, including chemotherapy agents and agents that provide a synergistic radiosensitizing effect. Methods of potentiating radiotherapy cancer treatment of cancers in humans, particularly of astrocytomas, are also presented, wherein a radiosensitizer composition is administered and radiotherapy is directed to the site of the tumor. Chemotherapy regimens may also be used as adjuvant therapy.
Radiosensitizer Formulations And Methods For Use
US Patent:
2010003, Feb 11, 2010
Filed:
Sep 24, 2009
Appl. No.:
12/566208
Inventors:
Richard H. Matthews - Jackson MO, US
Nuran Ercal - Rolla MO, US
Robert Zand - Ann Arbor MO, US
Nuran Ercal - Rolla MO, US
Robert Zand - Ann Arbor MO, US
International Classification:
A61K 31/417, A61P 35/00
US Classification:
514398
Abstract:
The present invention provides radiosensitizer compositions, in controlled-release formulations or other acceptable formulations, particularly nitrohistidine radiosensitizer compositions, which may be administered by any suitable means including oral, intravenous, arterial infusion, intraperitoneal, intramuscular, subcutaneous, surgical, and topical. Optionally, radiosensitizer compositions may be formulated with other agents, including chemotherapy agents and agents that provide a synergistic radiosensitizing effect. Methods of potentiating radiotherapy cancer treatment of cancers in humans, particularly of astrocytomas, are also presented, wherein a radiosensitizer composition is administered and radiotherapy is directed to the site of the tumor. Chemotherapy regimens may also be used as adjuvant therapy.